Protalix Biotherapeutics Inc (NYSE American:PLX)

0.444
Delayed Data
As of Jun 22
 -0.013 / -2.84%
Today’s Change
0.39
Today|||52-Week Range
0.92
-32.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-29.9M-27.3M-29.2M-85.3M
 
 
 
 
 
Depreciation3.1M2.4M2.0M1.9M
 
 
 
 
 
Total Other Cash Flow3.2M3.9M-6.0M44.3M
 
 
 
 
 
Funds From Operations-23.6M-21.0M-33.2M-39.1M
 
 
 
 
 
Funds From/For Other Operating Expenses5.7M3.3M-1.1M-29.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-29.3M-24.3M-32.1M-10.0M
 
 
 
 
 
 
InvestingCapital Expenditures-785.0K-464.0K-849.0K-971.0K
 
 
 
 
 
Fixed Asset Disposal11.0K3.0K20.0K3.0K
 
 
 
 
 
Other Investing - Uses-227.0K-96.0K-32.0K-5.0K
 
 
 
 
 
Other Investing - Sources0.0039.9M0.000.00
 
 
Net Cash Flow Investing-1.0M39.3M-861.0K-973.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings0.000.0019.7M9.5M
 
 
 
Long Term Debt Reduction0.000.00---11.0M
 
 
Net Proceeds Stock Sale46.0K6.6M14.0K0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00--0.000.00--
Cash Dividends Paid - Total0.00--0.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing46.0K6.6M19.7M-1.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.4M-131.0K277.0K414.0K
 
 
 
 
 
 
Net Change In Cash-30.2M21.7M-13.3M-12.4M